Jemapete Christopher J

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Gene Biotherapeutics Inc (CRXM)

Transaction date 17 Mar 2021

Purchase

Price

419.06

Quantity 45,632 -34.7%

Value US$1,714,477

Comments Filing

Gene Biotherapeutics Inc (CRXM)

Transaction date 16 Mar 2021

Purchase

Price

80.27

Quantity 75,680 -4.0%

Value US$4,726,133

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2021-03-18	2021-03-17	Gene Biotherapeutics Inc (CRXM)	B Purchase	45,632 -34.7% 419.06 US$1,714,477	45,632 -34.7%	419.06	US$1,714,477
2021-03-18	2021-03-16	Gene Biotherapeutics Inc (CRXM)	B Purchase	75,680 -4.0% 80.27 US$4,726,133	75,680 -4.0%	80.27	US$4,726,133